EUVIMEDEUVIMED entdecken
Crossref

pH and GSH dual-responsive drug-controlled nanomicelles for breast cancer treatment

Jingjing Xu, Xianjiao Tang, Xiaojing Yang iD, Mei-Xia Zhao iD

Biomedical Materials · 01.03.2023 · 18 (2) · 025021

DOI: 10.1088/1748-605x/acb7bb ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Materials, online erschienen am 22.02.2023. Verfasst von Jingjing Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Natural Medicine and Immune-Engineering of Henan Province, Henan University, Kaifeng 475004, People's Republic of China. Hauptthemen laut MEDLINE: Micelles, Breast Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Key Scientific and Technological Project of Henan Province, Natural Science Foundation of Henan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We developed a pH/glutathione (GSH) dual-responsive smart nano-drug delivery system to achieve targeted release of a chemotherapeutic drug at breast tumor site. Doxorubicin (DOX) was linked to polyethylene glycol (PEG) through cis-aconitic anhydride (CA) and disulfide bonds (SS) to obtain the PEG-SS-CA-DOX prodrug, which spontaneously assembled into nanomicelles with a particle size of 48 ± 0.45 nm. PEG-SS-CA-DOX micelles achieved an efficient and rapid release of DOX under dual stimulation by weak acidic pH and high GSH content of tumors, with the release amount reaching 88.0% within 48 h. Cellular uptake experiments demonstrated that PEG-SS-CA-DOX micelles could efficiently transport DOX into cells and rapidly release it in the tumor microenvironment. In addition, in vivo antitumor experiments showed that PEG-SS-CA-DOX had a high inhibition rate of 70% against 4T1 breast cancer cells along with good biosafety. In conclusion, dual-responsive smart nanomicelles can achieve tumor-targeted drug delivery and specific drug release, thus improving therapeutic efficacy of drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicellesBreast NeoplasmsHumansFemaleDoxorubicinPolyethylene GlycolsGlutathioneHydrogen-Ion ConcentrationDrug CarriersTumor Microenvironment

Stichwörter der Autor:innen

GSHdual-responsivenanomicellespHtumor

Substanzen

MicellesDoxorubicinPolyethylene GlycolsGlutathioneDrug Carriers

Autor:innen und Institutionen

  • Key Laboratory of Natural Medicine and Immune-Engineering of Henan Province, Henan University, Kaifeng 475004, People's Republic of China.

ORCID-Profile: Xiaojing Yang, Mei-Xia Zhao

Förderung

  • Key Scientific and Technological Project of Henan Province
  • Natural Science Foundation of Henan Province
  • National Natural Science Foundation of China
  • Major Cultivation Project of First-class Discipline of Henan University
  • Special Professor Project of Henan University

Zitieren

APA

Xu, J., Tang, X., Yang, X., & Zhao, M. X. (2023). pH and GSH dual-responsive drug-controlled nanomicelles for breast cancer treatment. Biomedical Materials, 18(2), 025021. https://doi.org/10.1088/1748-605x/acb7bb

Vancouver

Xu J, Tang X, Yang X, Zhao MX. pH and GSH dual-responsive drug-controlled nanomicelles for breast cancer treatment. Biomedical Materials. 2023;18(2):025021. doi:10.1088/1748-605x/acb7bb

BibTeX
@article{Xu2023,
  author = {Xu, Jingjing and Tang, Xianjiao and Yang, Xiaojing and Zhao, Mei-Xia},
  title = {pH and GSH dual-responsive drug-controlled nanomicelles for breast cancer treatment},
  journal = {Biomedical Materials},
  year = {2023},
  volume = {18},
  number = {2},
  pages = {025021},
  doi = {10.1088/1748-605x/acb7bb}
}
Kostenlos starten →